European Parliament, Council of the European Union. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices, Amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and Repealing Council Directives 90/385/EEC and 93/42/EEC. OJ L vol. 117 (2017).
European Parliament, Council of the European Union. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance). http://data.europa.eu/eli/reg/2017/746/oj/eng (2017).
European Parliament, Council of the European Union. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 Laying down Harmonised Rules on Artificial Intelligence and Amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act). (2024).
European Commission. Proposal for Amending Regulations (EU) 2017/745 and (EU) 2017/746. COM(2025) 1023 (2025).
Ben-Menahem, S. M., Nistor-Gallo, R., Macia, G., von Krogh, G. & Goldhahn, J. How the new European regulation on medical devices will affect innovation. Nat. Biomed. Eng. 4, 585–590 (2020).
Carl, A.-K. & Hochmann, D. Impact of the new European medical device regulation: a two-year comparison. Biomed. Tech. (Berl.) 69, 317–326 (2024).
Freyer, O. The regulation of medical devices in developing EU frameworks. (TU Dresden, Dresden, Germany, 2025).
Melvin, T. The European Medical Device Regulation-what biomedical engineers need to know. IEEE J. Transl. Eng. Health Med. 10, 4800105 (2022).
Svempe, L. Impact of the new European medical device regulation on digital health manufacturers. NPJ Digit. Med. 9, 638 (2026).
McDermott, O. & Kearney, B. A review of the literature on the new European Medical Device Regulations requirements for increased clinical evaluation. Int. J. Pharm. Healthc. Mark. 19, 1–21 (2025).
Widmann, M. Mangel an Medizinprodukten: Plötzlich ein Loch im Kinderherz – weil ein Teil für wenige Euro fehlt. Die Zeit (2024).
MedTech Europe. MedTech Europe IVDR & MDR Survey Results 2024. https://www.medtecheurope.org/wp-content/uploads/2025/01/mte_report_ivdr_mdr_2024-v7.pdf (2024).
Draghi, M. The Draghi Report on EU Competitiveness. https://commission.europa.eu/topics/eu-competitiveness/draghi-report_en (2024).
European Commission. COMMISSION STAFF WORKING DOCUMENT EVALUATION on the Targeted Evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostic Medical Devices Accompanying the Document Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL Amending Regulations (EU) 2017/745 and (EU) 2017/746 as Regards Simplifying and Reducing the Burden of the Rules on Medical Devices and in Vitro Diagnostic Medical Devices, and Amending Regulation (EU) 2022/123 as Regards the Support of the European Medicines Agency for the Expert Panels on Medical Devices and Regulation (EU) 2024/1689 as Regards the List of Union Harmonisation Legislation Referred to in Its Annex I. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:52025SC1051 (2025).
Schenk, O. DRAFT REPORT on the Proposal for a Regulation of the European Parliament and of the Council Amending Regulations (EU) 2017/745 and (EU) 2017/746 as Regards Simplifying and Reducing the Burden of the Rules on Medical Devices and in Vitro Diagnostic Medical Devices, and Amending Regulation (EU) 2022/123 as Regards the Support of the European Medicines Agency for the Expert Panels on Medical Devices and Regulation (EU) 2024/1689 as Regards the List of Union Harmonisation Legislation Referred to in Its Annex I (COM(2025)1023 – C10-0360/2025 – 2025/0404(COD)). https://www.europarl.europa.eu/doceo/document/SANT-PR-787987_EN.html (2026).
European Parliament, Council of the European Union. Regulation (EU) 2026/1744 of the European Parliament and of the Council of 8 July 2026 Amending Regulations (EU) 2024/1689, (EU) 2018/1139 and (EU) 2023/1230 as Regards the Simplification of the Implementation of Harmonised Rules on Artificial Intelligence (Digital Omnibus on AI) (2026).
Gerhart, M. MDR Rule 11: The Classification Nightmare. Johner Institute. https://blog.johner-institute.com/regulatory-affairs/mdr-rule-11/ (2026).
IMDRF Software as a Medical Device (SaMD) Working Group. “Software as a Medical Device”: Possible Framework for Risk Categorization and Corresponding Considerations. https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf (2014).
IMDRF Software as a Medical Device Working Group. Characterization Considerations for Medical Device Software and Software-Specific Risk. https://www.imdrf.org/sites/default/files/2025-01/IMDRF_SaMD%20WG_Software-Specific%20Risk_N81%20Final_0.pdf (2025).
Rosenthal, J. T., Beecy, A. & Sabuncu, M. R. Rethinking clinical trials for medical AI with dynamic deployments of adaptive systems. NPJ Digit. Med. 8, 252 (2025).
European Parliament, Council of the European Union. Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on Health Technology Assessment and Amending Directive 2011/24/EU (2021).
Gilbert, S. Digital medicine’s international race for regulatory sandboxes and voluntary alternative pathways picks up tempo. NPJ Digit. Med. 9, 190 (2026).
European Commission. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006. https://eur-lex.europa.eu/resource.html?uri=cellar:e3f40e76-e437-11ed-a05c-01aa75ed71a1.0001.02/DOC_1&format=PDF (2023).
European Commission. Proposal for a Regulation to Establish Measures to Strengthen the Union’s Biotechnology and Biomanufacturing Sectors (European Biotech Act). (2025).
Subbaswamy, A. & Saria, S. From development to deployment: dataset shift, causality, and shift-stable models in health AI. Biostatistics 21, 345–352 (2020).
Freyer, O., Jayabalan, S., Kather, J. N. & Gilbert, S. Overcoming regulatory barriers to the implementation of AI agents in healthcare. Nat. Med. 31, 3239–3243 (2025).
Kiyasseh, D., Zhu, T. & Clifton, D. A clinical deep learning framework for continually learning from cardiac signals across diseases, time, modalities, and institutions. Nat. Commun. 12, 4221 (2021).
Ferber, D. et al. Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology. Nat. Cancer 6, 1337–1349 (2025).
Freyer, O. et al. The regulation of artificial intelligence in intensive care units: from narrow tools to generalist systems. NPJ Digit. Med. 9, 246 (2026).
Gallifant, J. et al. An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation study. medRxiv (2026) https://doi.org/10.64898/2026.02.26.26347179.
